
Opinion|Videos|August 20, 2025
Adverse Events Associated With Conventional Alopecia Areata Therapies
Key Takeaways
- Alopecia areata is a chronic autoimmune disorder causing non-scarring hair loss due to immune system attacks on hair follicles.
- Breakdown of immune privilege in hair follicles leads to infiltration by cytotoxic T cells, particularly CD8+ T cells.
Panelists discuss how adverse events associated with conventional therapies for alopecia areata (AA) are monitored through regular patient assessments, and how these events are managed by adjusting treatment or providing supportive care as needed.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- McMichael: How do you monitor adverse events with conventional therapies while treating patients for AA?
- How do you manage these events if they occur?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer
3
Atacicept Becomes First BAFF/APRIL Inhibitor Approved for IgA Nephropathy: Richard Lafayette, MD
4
Boston Panel Confronts Access and Coordination Gaps in Obesity Care
5



